Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Estradiol/etonogestrel intravaginal ring - Merck

Next Previous
Drug Profile

Estradiol/etonogestrel intravaginal ring - Merck

Alternative Names: ENG-CVR; ENG-E2; ENG/CVR; Etonogestrel/17β-estradiol; Etonogestrel/estradiol intravaginal ring; MK-8342B; SCH 900432

Latest Information Update: 24 Oct 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Merck & Co
  • Class Estradiol congeners; Estrenes; Hormonal contraceptives; Hormonal replacements; Norpregnanes; Progesterone congeners; Small molecules
  • Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Dysmenorrhoea; Pregnancy

Most Recent Events

  • 28 Feb 2017 Discontinued - Phase-II for Dysmenorrhoea in Germany, Netherlands, Spain, Denmark, Norway (Vaginal) due to business reasons (Merck Annual report 2016)
  • 28 Feb 2017 Discontinued - Phase-III for Dysmenorrhoea in Finland, USA, Sweden, Poland (Vaginal) due to business reasons (Merck Annual report 2016)
  • 28 Feb 2017 Discontinued - Phase-III for Pregnancy (Prevention) in USA, Puerto Rico, Norway, Finland, Netherlands, Germany, Spain, Hungary, Poland, Sweden, Austria, Denmark, Czech Republic (Vaginal) due to business reasons (Merck Annual report 2016)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top